IP Library Granted Patent US 10,683,526
Granted Patent B2
US 10,683,526 · App. 15/694,524 · Granted Jun 16, 2020

High-purity steviol glycosides

Inventors: Avetik Markosyan (Yerevan, AM); Indra Prakash (Alpharetta, GA); Cynthia Bunders (Atlanta, GA); Pankaj Soni (Kennesaw, GA); Jarrin Cyrille (Muret, FR); Aurélien Badie (Lebége, FR); Robert ter Halle (Baziege, FR)
Assignee: PureCircle Sdn Bhd
C12P19/56A23L2/60A23L27/33A24B15/10A24B15/302C07H15/256A23V2002/00Y02P20/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,683,526
App. No.
15/694,524
Granted
Jun 16, 2020
Kind
B2
Abstract

Methods of preparing highly purified steviol glycosides, particularly rebaudiosides A, D and M are described. The methods include utilizing recombinant microorganisms for converting various staring compositions to target steviol glycosides. In addition, novel steviol glycosides reb D2 and reb M2 are disclosed, as are methods of preparing the same. The highly purified rebaudiosides are useful as non-caloric sweetener in edible and chewable compositions such as any beverages, confectioneries, bakery products, cookies, and chewing gums.

Claims (15)

1. A method for producing highly purified target steviol glycoside rebaudioside M2, having the following structure:

comprising the steps of:

a. providing an aqueous solution comprising a starting composition comprising steviol glycosides;

b. providing a microorganism selected from the group consisting of E. coli, Saccharomyces species, Aspergillus species, Pichia species, Bacillus species, and Yarrowia species;

said microorganism comprising at least one exogenous gene-encoded steviol biosynthesis enzyme selected from the group consisting of: geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase, steviol synthetase, deoxyxylulo se 5-phosphate synthase, D-1-deoxyxylulose 5-phosphate reductoisomerase, 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase, 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase, 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase, acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, and cytochrome P450 reductase, and a combination thereof;

said microorganism further comprising an exogenous gene-encoded uridine diphosphate (UDP)-glycosyltransferases capable of adding at least one glucose unit to the steviol glycoside to provide the target steviol glycoside;

said microorganism further optionally comprising an exogenous gene-encoded UDP-glucose recycling enzymes; and

c. contacting the microorganism with a medium containing the starting composition to produce a medium comprising at least one target steviol glycoside.

2. The method of claim 1 further comprising the step of:

d. separating the target steviol glycoside from the medium to provide a highly purified target steviol glycoside composition.

3. The method of claim 1 , wherein the steviol biosynthesis enzyme is provided as a biocatalyst selected from the group consisting of whole cell suspension, crude lysate or purified enzymes in free or immobilized form.

4. The method of claim 1 , wherein the target steviol glycoside is produced within a cell or in the medium and is separated using crystallization, separation by membranes, centrifugation, extraction, chromatographic separation or a combination thereof.

5. Rebaudioside M2 having the structure:

6. The method of claim 1 , wherein the UDP-glycosyltransferase (UGT) is selected from the group consisting of: UGT of Solanum lycoperiscum origin (UGTSL); UGTSL2; UGTSL produced in Saccharomyces cerevisiae (UGTSL Sc); UGT74G1; UGT85C2; UGT76G1; UGT91D2; and isolated nucleic acid molecules that code for UGTSL, UGTSL2, UGTSL Sc, UGT74G1, UGT85C2, UGT76G1, or UGT91D2.

7. The method of claim 1 , wherein said microorganism further comprises exogenous gene-encoded UDP-glucose recycling enzymes.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2020
From: MARKOSYAN, AVETIK; PRAKASH, INDRA; BUNDERS, CYNTHIA; SONI, PANKAJ; CYRILLE, JARRIN; BADIE, AURELIEN; TER HALLE, ROBERT
To: PURECIRCLE SDN BHD
Reel/Frame 051641/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: THE COCA-COLA COMPANY
To: PURECIRCLE SDN BHD
Reel/Frame 046787/0788 →
Continuity (18)
Continuation 14287837 · May 27, 2014
Continuation In Part 15400325 · Jan 6, 2017
Continuation In Part 15694524 · Sep 1, 2017
Continuation 14954213 · Nov 30, 2015
Division 14469076 · Aug 26, 2014
Continuation PCTUS2013030439 · Mar 12, 2013
Provisional Application 61827922 · May 28, 2013
Provisional Application 61939855 · Feb 14, 2014
Provisional Application 61649978 · May 22, 2012
Provisional Application 61843544 · Jul 8, 2013
Provisional Application 61913482 · Dec 9, 2013
Provisional Application 61861528 · Aug 2, 2013
Provisional Application 61881166 · Sep 23, 2013
Provisional Application 61885084 · Oct 1, 2013
Provisional Application 61904751 · Nov 15, 2013
Provisional Application 61921635 · Dec 30, 2013
Provisional Application 61925329 · Jan 9, 2014
Related Publication 20180100175A1 · Apr 12, 2018